Literature DB >> 3009845

Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody.

F L Homa, D J Purifoy, J C Glorioso, M Levine.   

Abstract

Previously (Holland et al., J. Virol. 52:566-574, 1984; Kikuchi et al., J. Virol. 52:806-815, 1984) we described the isolation and partial characterization of over 100 herpes simplex virus type 1 mutants which were resistant to neutralization by a pool of glycoprotein C- (gC) specific monoclonal antibodies. The genetic basis for the inability of several of these gC- mutants to express an immunoreactive envelope form of gC is reported here. Comparative nucleotide sequence analysis of the gC gene of the six mutants gC-3, gC-8, gC-49, gC-53, gC-85, and synLD70, which secrete truncated gC polypeptides, with that of the wild-type KOS 321 gC gene revealed that these mutant phenotypes were caused by frameshift or nonsense mutations, resulting in premature termination of gC translation. Secretion of the gC polypeptide from cells infected with these mutants was due to the lack of a functional transmembrane anchor sequence. The six secretor mutants were tested for suppression of amber mutations in mixed infection with a simian virus 40 amber suppressor vector. Mutant gC-85 was suppressed and produced a wild-type-sized membrane-bound gC. Nucleotide sequence analysis of the six gC deletion mutants gC-5, gC-13, gC-21, gC-39, gC-46, and gC-98 revealed that they carried identical deletions which removed 1,702 base pairs of the gC gene. The deletion, which was internal to the gC gene, removed the entire gC coding sequence and accounted for the novel 1.1-kilobase mRNA previously seen in infections with these mutants. The mutant gC-44 was previously shown to produce a membrane-bound gC protein indistinguishable in molecular weight from wild-type gC. This mutant differed from wild-type virus in that it had reduced reactivity with virus-neutralizing monoclonal antibodies. Nucleotide sequence analysis of the gC gene of mutant gC-44 demonstrated a point mutation which changed amino acid 329 of gC from a serine to a phenylalanine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009845      PMCID: PMC252911     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.

Authors:  B Norrild; S L Shore; A J Nahmias
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.

Authors:  G Kümel; H C Kaerner; M Levine; C H Schröder; J C Glorioso
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.

Authors:  W T Ruyechan; L S Morse; D M Knipe; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

4.  Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.

Authors:  K L Powell; A Buchan; C Sim; D H Watson
Journal:  Nature       Date:  1974-05-24       Impact factor: 49.962

5.  Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies.

Authors:  L Pereira; D V Dondero; D Gallo; V Devlin; J D Woodie
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1.

Authors:  R Eberle; R J Courtney
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

Review 8.  Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis.

Authors:  B F Vestergaard
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

9.  Herpes simplex virus type 1 HindIII fragment L encodes spliced and complementary mRNA species.

Authors:  R J Frink; K P Anderson; E K Wagner
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

10.  Cloning of herpes simplex virus type 1 sequences representing the whole genome.

Authors:  A L Goldin; R M Sandri-Goldin; M Levine; J C Glorioso
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

View more
  22 in total

1.  Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.

Authors:  K A Kimmel; K E Dolter; G M Toth; M Levine; J C Glorioso
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein C.

Authors:  C Seidel-Dugan; M Ponce de Leon; H M Friedman; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration.

Authors:  A O Fuller; R E Santos; P G Spear
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.

Authors:  D WuDunn; P G Spear
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  The cytoplasmic domain of herpes simplex virus type 1 glycoprotein C is required for membrane anchoring.

Authors:  T C Holland; R J Lerch; K Earhart
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.

Authors:  C T Wu; M Levine; F Homa; S L Highlander; J C Glorioso
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA.

Authors:  F L Homa; T M Otal; J C Glorioso; M Levine
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

8.  Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.

Authors:  S Laquerre; R Argnani; D B Anderson; S Zucchini; R Manservigi; J C Glorioso
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.

Authors:  K E Dolter; W F Goins; M Levine; J C Glorioso
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Authors:  R Tal-Singer; C Peng; M Ponce De Leon; W R Abrams; B W Banfield; F Tufaro; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.